I am with you horsemin. I think people waiting for these results and FDA feedback to consolidate holdings. IMO this will then push the emphasis to a licencing agreement which should occur soon after. Worthind has shown that the market for this drug is definitely there and it is going to make AVX very good money even on a 20% agreement. I am still looking for the exit door, but if all comes to plan this BIO could fly and offer us returns like ADO holders were enjoying for a couple of days. That would make the exit door a nice gold one indeed. At least this is what I am hoping, but I feel it may still only make me my money back! All my opinions only so DYOR.
Watching, waiting, hoping, holding. GLTA.
sads.
- Forums
- ASX - By Stock
- AVX
- under the radar
under the radar, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit